General Information of the Protein
Protein ID |
PT03632
|
||||
---|---|---|---|---|---|
Protein Name |
Sigma intracellular receptor 2
|
||||
Secondarily Protein Name |
Meningioma-associated protein 30
Transmembrane protein 97
|
||||
Gene Name |
TMEM97
|
||||
Secondarily Gene Name |
MAC30
S2R
|
||||
Sequence |
MGAPATRRCVEWLLGLYFLSHIPITLFMDLQAVLPRELYPVEFRNLLKWYAKEFKDPLLQEPPAWFKSFLFCELVFQLPFFPIATYAFLKGSCKWIRTPAIIYSVHTMTTLIPILSTFLFEDFSKASGFKGQRPETLHERLTLVSVYAPYLLIPFILLIFMLRSPYYKYEEKRKKK
Show/Hide
|
||||
Organism |
Homo sapiens, Human
|
||||
Protein Classification |
Membrane receptor
|
||||
Function |
Intracellular sigma-2 receptor that binds histatin 1/HN1 (Hst 1) at the endoplasmic reticulun (ER) membrane, which is critical for mitochondrial-targeting and -activating properties of Hst1 (PubMed:34233061, PubMed:35970844). Thought to play important role in regulating cell survival, morphology and differentiation (PubMed:23922215, PubMed:25620095). May play a role as a regulator of cellular cholesterol homeostasis (PubMed:19583955). May function as sterol isomerase (PubMed:25566323). May alter the activity of some cytochrome P450 proteins (PubMed:22292588).
Show/Hide
|
||||
Uniprot ID |
Show/Hide
|
||||
Ensembl ID | |||||
HGNC ID | |||||
Subcellular Location |
Nucleus membrane
Rough endoplasmic reticulum membrane
|
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein Protein Cell Line Compound Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000025 , HEK-293T
Cell Line ID: CL000006 , HEK293
Cell Line ID: CL000001 , Jurkat
Cell Line ID: CL000996 , RT-4
Cell Line ID: CL000013 , Sf9
Biochemical Assays
Compound ID | Compound Name | Compound Formula | |
CP0013421 |
CAS_97-39-2
Show/Hide
|
C15H17N3
|
2 |
1 | Ki = 18 nM | ||
---|---|---|---|
2 | Ki = 28.4 nM |
Clinical Information about the Protein
Target 1 ( Sigma intracellular receptor 2 (TMEM97) )
Target Type | Clinical trial Target | ||||
---|---|---|---|---|---|
Disease | 1 Target-related Disease | 1 | |||
1 | Alzheimer disease [ICD-11: 8A20] | ||||
Clinical Trial Drug(s) | 1 Clinical Trial Drug | 1 | |||
1 | CT1812 | Phase 2 |
Target 2 ( HUMAN sigma intracellular receptor 2 (TMEM97) )
Target Type | Unknown Type Target | ||||
---|---|---|---|---|---|
Disease | 2 Target-related Diseases | 2 | |||
1 | Schizophrenia [ICD-11: 6A20] | ||||
2 | Coronavirus Disease 2019 (COVID-19) [ICD-11: 1D6Y] | ||||
Investigative Drug(s) | 2 Investigative Drugs | 2 | |||
1 | Haloperidol | Approved | |||
2 | PB28 | Investigative |